- Home
- RNA vs FCPT Comparison
RNA vs FCPT Comparison
Compare RNA & FCPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- FCPT
- Stock Information
- Founded
- RNA 2012
- FCPT 2015
- Country
- RNA United States
- FCPT United States
- Employees
- RNA N/A
- FCPT N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- FCPT Real Estate Investment Trusts
- Sector
- RNA Health Care
- FCPT Real Estate
- Exchange
- RNA Nasdaq
- FCPT Nasdaq
- Market Cap
- RNA 3.2B
- FCPT 2.9B
- IPO Year
- RNA 2020
- FCPT N/A
- Fundamental
- Price
- RNA $26.66
- FCPT $28.24
- Analyst Decision
- RNA Strong Buy
- FCPT Buy
- Analyst Count
- RNA 12
- FCPT 7
- Target Price
- RNA $68.25
- FCPT $30.50
- AVG Volume (30 Days)
- RNA 1.9M
- FCPT 1.0M
- Earning Date
- RNA 05-08-2025
- FCPT 04-30-2025
- Dividend Yield
- RNA N/A
- FCPT 5.12%
- EPS Growth
- RNA N/A
- FCPT N/A
- EPS
- RNA N/A
- FCPT 1.07
- Revenue
- RNA $10,897,000.00
- FCPT $268,072,999.00
- Revenue This Year
- RNA N/A
- FCPT $8.15
- Revenue Next Year
- RNA $135.33
- FCPT $9.74
- P/E Ratio
- RNA N/A
- FCPT $26.39
- Revenue Growth
- RNA 13.98
- FCPT 6.97
- 52 Week Low
- RNA $21.51
- FCPT $22.38
- 52 Week High
- RNA $56.00
- FCPT $30.93
- Technical
- Relative Strength Index (RSI)
- RNA 45.21
- FCPT 54.49
- Support Level
- RNA $25.28
- FCPT $25.01
- Resistance Level
- RNA $27.67
- FCPT $27.80
- Average True Range (ATR)
- RNA 2.36
- FCPT 0.95
- MACD
- RNA -0.03
- FCPT 0.05
- Stochastic Oscillator
- RNA 56.41
- FCPT 81.57
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About FCPT Four Corners Property Trust Inc.
Four Corners Property Trust Inc is a real estate investment trust predominantly engaged in the ownership, acquisition and leasing of restaurant and retail properties. The company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries. The firm operates through two segments namely, real estate operations and restaurant operations. The real estate operations segment consists of rental revenues generated by leasing restaurant and retail properties to tenants. The restaurant operations segment is conducted through a taxable REIT subsidiary (TRS) and consists of Kerrow Restaurant Operating Business. The firm generates majority of the revenue from the real estate operations segment.